RFK Jr.'s AI Embrace Sparks Controversy Among Allies and Medical Experts

Health Secretary Robert F. Kennedy Jr. has garnered a significant following by voicing concerns about the influence of powerful industries, including pharmaceuticals, processed foods, and pesticides. However, his recent endorsement of artificial intelligence at a "Make America Healthy Again" (MAHA) summit has created friction within his movement and raised questions among medical professionals.

At the summit, which included AI and Silicon Valley executives, Kennedy stated that AI technology could liberate Americans from "medical tyranny" by enabling them to independently verify medical advice. "We’re never ever again going to be able to be dominated by public officials who tell us: ‘Trust the experts,’" he told the audience.

This stance has drawn criticism from some prominent MAHA figures who perceive it as a departure from the movement's initial focus on scrutinizing corporate interests. Simultaneously, medical experts argue that Kennedy's view of AI as a countermeasure to the medical establishment is flawed.

"He obviously doesn’t understand how AI works," said Dr. Zeke Emanuel, a cancer specialist and bioethicist at the University of Pennsylvania. "AI aggregates the information we have in the medical literature and in case studies. And that means what you’re actually getting is medical expertise."

Companies like OpenAI and Anthropic offer health-focused chatbots that analyze medical records and answer health-related queries. These models are trained on extensive medical literature and professional guidelines, incorporating feedback from physicians. Emanuel suggested that Kennedy's desire for AI to validate his specific viewpoints differs from the intended function of advanced AI.

HHS spokesperson Emily Hilliard countered that Emanuel was describing a limited application of the technology. She explained that Kennedy aims to empower individuals with their health data, using AI to help them understand, question, and compare it with evidence, thereby facilitating better decision-making with their doctors. Hilliard also noted that AI could potentially enhance physician efficiency, allowing more time for patient care.

Several companies, including OpenAI and Anthropic, sponsored the MAHA Summit. Many sponsors have pending business before the U.S. government, including those involved in psychedelic drugs, fitness wearables, and experimental cancer tests. Sponsorships reportedly ranged up to $300,000, with some companies receiving speaking opportunities alongside administration health officials.

Dr. Robert Malone, a vaccine researcher and former member of a federal vaccine panel under Kennedy, described the event as "classic pay-to-play." He and other MAHA movement figures expressed concern that large corporations are supplanting the grassroots activists who initially propelled the movement. Malone stated that individuals at the core of MAHA, including physicians and patient advocates, were not represented at the summit.

The summit was organized by MAHA Center Inc., one of several non-governmental groups affiliated with Kennedy associates that promote his agenda. Tony Lyons, who leads the MAHA Center and related entities, addressed criticisms regarding corporate sponsorships by emphasizing the goal of building a broad movement to achieve tangible results.

Kennedy's engagement with Silicon Valley aligns with trends seen within the Trump administration. Former President Donald Trump has resisted increased oversight for AI companies, viewing them as drivers of stock market growth. His administration has taken steps to allow the AI industry to self-regulate and has downplayed concerns about data centers' environmental impact.

Concurrently, health officials have promoted AI as a solution for various U.S. health challenges, including escalating medical costs, healthcare fraud, physician shortages, and the closure of rural hospitals. Medicare has engaged in discussions with AI chatbot companies, exploring programs like an AI-enabled prescription refill system in Utah.

Glenn Cohen, a bioethics expert at Harvard Law School, characterizes the views on AI's potential as "techno-utopian." He expressed surprise at Kennedy's alignment with AI companies, given his past focus on curbing industry practices he deems harmful to consumers.

Some MAHA organizations, such as Moms Across America, are actively campaigning against AI-related industries, particularly concerning the environmental impact of data centers. The group, founded by a former staffer for Kennedy's presidential campaign, did not respond to a request for comment.

AI experts acknowledge the transformative potential of AI in healthcare but emphasize that its adoption is likely to reinforce established medical knowledge rather than support contrarian viewpoints. Dr. Robert Wachter, a medical technology expert at the University of California, San Francisco, believes AI can empower patients with more health insights but noted that its widespread adoption will likely bolster professional medical recommendations.

While studies have shown AI's efficacy in controlled scenarios, real-world applications reveal challenges. Patients may not provide sufficient information for accurate diagnosis, and AI responses can be a mix of accurate and inaccurate advice. Wachter highlighted the need to assess AI's actual effectiveness and interpretability in dynamic, real-life situations, especially under stress or when users struggle to understand the output.